All posts tagged in aimed at curbing kickbacks and misuse of public funds. The timing is particularly sensitive for AstraZeneca

In a significant development for the pharmaceutical giant AstraZeneca, Chinese authorities have reportedly detained five current and former employees as part of an investigation into potential breaches of data privacy